CAS No.:84-17-3

TOXICITY DATA with REFERENCE：

1.		sce-hmn:fbr 5 nmol/L		NATUAS    Nature. 281 (1979),392.
2.		dns-ham:emb 3 mg/L		CNREA8    Cancer Research. 44 (1984),184.

Consensus Reports：

IARC Cancer Review: Animal Inadequate Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 21 (1979),p. 161.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Limited Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 21 (1979),p. 161.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) .

SAFETY PROFILE：

Suspected human carcinogen. Human mutation data reported. Experimental reproductive effects. Used as a drug for the treatment of postmenopausal symptoms. When heated to decomposition it emits acrid smoke and irritating fumes.
Hazard Codes:
Xn: Harmful
Risk Statements about Dehydrostilbestrol (84-17-3):
R40 Limited evidence of a carcinogenic effect.
R48 Danger of serious damage to health by prolonged exposure.
Safety Statements about Dehydrostilbestrol (84-17-3):
S22 Do not breathe dust.
S24/25: Avoid contact with skin and eyes.

Standards and Recommendations：

 

Analytical Methods：